Investing Profile

Paul Klingenstein

Your Intro Paths to Paul Klingenstein

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Paul Klingenstein on

Current Investing Position

Aberdare Ventures Managing Partner

Investment Range

$500K - $15.0M

Sweet Spot

$8.0M

Investments On Record

Paul Klingenstein is on these Sector & Stage Rankings

Paul Klingenstein's Investments On Record (6)

Company	StageDateRound Size	Total Raised
MC10	Series UnknownAug 2018$10M Series CDec 2012$10M Series UnknownJan 2012$2M	$60M
Co-investors: Carmichael Roberts (Breakthrough Energy Ventures), Marc Singer (Osage University Partners), Mark Goodman (MassMutual Ventures)
Aviir	Series BJun 2013$10M Series BFeb 2013$10M Series UnknownDec 2011$10M Series UnknownJun 2011$3M Series UnknownJan 2010$4M Series UnknownOct 2009$1M Series UnknownDec 2008$8M Series UnknownMar 2008$2M Series BSep 2007$11M	$59M
Co-investors: David Rubin (Merck Global Health Innovation Fund)
Nevro	Series BJul 2011$58M Series ASep 2008$22M SeedDec 2006$6M	$130M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Asish Xavier (Johnson & Johnson Innovation)
Posit Science	Series UnknownMar 2011$3M Series UnknownApr 2009$6M Series BDec 2006$15M	$24M
Conatus Pharmaceuticals	Series BFeb 2011$20M Series AMay 2007$22M	$50M
Co-investors: Jim Scopa (MPM Capital), Shahzad Malik (Advent Life Sciences)
Anacor Pharmaceutical	Series EJan 2009$50M Series CMay 2005$25M Series UnknownNov 2002$4M Series AJul 2002$3M	$87M
Co-investors: Ling Wong (Highbury Group), Anders Hove (Acorn Bioventures)